NEXTCURE, INC Diluted Shares Outstanding (Weighted Average)
NEXTCURE, INC (NXTC) reported Diluted Shares Outstanding (Weighted Average) of 5.31 million shares for the 3-month period ending 2026-06-30, per its S-4 filed 2026-08-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-08-18
- NEXTCURE, INC weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 5.31M shares, a 123.59% increase year-over-year.
- NEXTCURE, INC weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 5.24M shares, a 124.49% increase year-over-year.
- NEXTCURE, INC weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 3.98M shares, a 70.59% increase year-over-year.
- NEXTCURE, INC weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 2.68M shares, a 14.79% increase year-over-year.
- NEXTCURE, INC weighted average number of shares outstanding, diluted for fiscal 2023 was 27.84M shares, a 0.33% increase from fiscal 2022.
- NEXTCURE, INC weighted average number of shares outstanding, diluted for fiscal 2022 was 27.74M shares, a 0.46% increase from fiscal 2021.
- NEXTCURE, INC weighted average number of shares outstanding, diluted for fiscal 2021 was 27.62M shares, a 0.30% increase from fiscal 2020.
- NEXTCURE, INC weighted average number of shares outstanding, diluted for fiscal 2020 was 27.53M shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 6 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 9 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 5.31M shares S-4 · filed 2026-08-18 | 5.27M shares S-4 · filed 2026-08-18 | 4.84M shares derived: average of 3 quarters · filed 2026-08-18 | 4.30M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2026-03-31 | 5.24M shares 10-Q · filed 2026-05-07 | 4.61M shares derived: average of 2 quarters · filed 2026-08-18 | 3.97M shares derived: average of 3 quarters · filed 2026-08-18 | 3.57M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2025-12-31 | 3.98M shares derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18 | 3.33M shares derived: average of 2 quarters · filed 2026-08-18 | 3.01M shares derived: average of 3 quarters · filed 2026-08-18 | 2.84M shares S-4 · filed 2026-08-18 | ||||
| 2025-09-30 | 2.68M shares 10-Q · filed 2025-11-05 | 2.53M shares derived: average of 2 quarters · filed 2026-08-18 | 2.46M shares 10-Q · filed 2025-11-05 | 2.43M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2025-06-30 | 2.37M shares S-4 · filed 2026-08-18 | 2.35M shares S-4 · filed 2026-08-18 | 2.35M shares derived: average of 3 quarters · filed 2026-08-18 | 2.34M shares derived: average of 4 quarters · filed 2026-08-18 | ||||
| 2025-03-31 | 2.33M shares 10-Q · filed 2026-05-07 | 28.01M shares 10-Q · filed 2025-05-01 | 2.33M shares derived: average of 2 quarters · filed 2026-08-18 | 2.33M shares derived: average of 3 quarters · filed 2026-08-18 | 2.33M shares derived: average of 4 quarters · filed 2026-08-18 | |||
| 2024-12-31 | 2.33M shares derived: S-4 12 month − 10-Q 9 month · filed 2026-08-18 | 2.33M shares derived: average of 2 quarters · filed 2026-08-18 | 2.33M shares derived: average of 3 quarters · filed 2026-08-18 | 2.33M shares S-4 · filed 2026-08-18 | 27.96M shares 10-K · filed 2025-03-06 | |||
| 2024-09-30 | 2.33M shares 10-Q · filed 2025-11-05 | 27.98M shares 10-Q · filed 2024-11-07 | 2.33M shares derived: average of 2 quarters · filed 2025-11-05 | 2.33M shares 10-Q · filed 2025-11-05 | 27.95M shares 10-Q · filed 2024-11-07 | 15.12M shares derived: average of 4 quarters · filed 2025-11-05 | ||
| 2024-06-30 | 2.33M shares 10-Q · filed 2025-08-07 | 27.97M shares 10-Q · filed 2024-08-01 | 2.33M shares 10-Q · filed 2025-08-07 | 27.94M shares 10-Q · filed 2024-08-01 | 19.38M shares derived: average of 3 quarters · filed 2025-08-07 | 21.49M shares derived: average of 4 quarters · filed 2025-08-07 | ||
| 2024-03-31 | 27.90M shares 10-Q · filed 2025-05-01 | 27.90M shares derived: average of 2 quarters · filed 2025-05-01 | 27.88M shares derived: average of 3 quarters · filed 2025-05-01 | 27.87M shares derived: average of 4 quarters · filed 2025-05-01 | ||||
| 2023-12-31 | 27.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 27.87M shares derived: average of 2 quarters · filed 2025-03-06 | 27.86M shares derived: average of 3 quarters · filed 2025-03-06 | 27.84M shares 10-K · filed 2025-03-06 | ||||
| 2023-09-30 | 27.84M shares 10-Q · filed 2024-11-07 | 27.83M shares derived: average of 2 quarters · filed 2024-11-07 | 27.81M shares 10-Q · filed 2024-11-07 | 27.80M shares derived: average of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | 27.83M shares 10-Q · filed 2024-08-01 | 27.80M shares 10-Q · filed 2024-08-01 | 27.79M shares derived: average of 3 quarters · filed 2024-08-01 | 27.78M shares derived: average of 4 quarters · filed 2024-08-01 | ||||
| 2023-03-31 | 27.77M shares 10-Q · filed 2024-05-02 | 27.77M shares derived: average of 2 quarters · filed 2024-05-02 | 27.77M shares derived: average of 3 quarters · filed 2024-05-02 | 27.76M shares derived: average of 4 quarters · filed 2024-05-02 | ||||
| 2022-12-31 | 27.77M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-21 | 27.76M shares derived: average of 2 quarters · filed 2024-03-21 | 27.76M shares derived: average of 3 quarters · filed 2024-03-21 | 27.74M shares 10-K · filed 2024-03-21 | ||||
| 2022-09-30 | 27.75M shares 10-Q · filed 2023-11-02 | 27.75M shares derived: average of 2 quarters · filed 2023-11-02 | 27.73M shares 10-Q · filed 2023-11-02 | 27.71M shares derived: average of 4 quarters · filed 2023-11-02 | ||||
| 2022-06-30 | 27.74M shares 10-Q · filed 2023-08-03 | 27.73M shares 10-Q · filed 2023-08-03 | 27.70M shares derived: average of 3 quarters · filed 2023-08-03 | 27.68M shares derived: average of 4 quarters · filed 2023-08-03 | ||||
| 2022-03-31 | 27.71M shares 10-Q · filed 2023-05-04 | 27.67M shares derived: average of 2 quarters · filed 2023-05-04 | 27.65M shares derived: average of 3 quarters · filed 2023-05-04 | 27.64M shares derived: average of 4 quarters · filed 2023-05-04 | ||||
| 2021-12-31 | 27.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 27.63M shares derived: average of 2 quarters · filed 2023-03-02 | 27.62M shares derived: average of 3 quarters · filed 2023-03-02 | 27.62M shares 10-K · filed 2023-03-02 | ||||
| 2021-09-30 | 27.62M shares 10-Q · filed 2022-11-03 | 27.61M shares derived: average of 2 quarters · filed 2022-11-03 | 27.61M shares 10-Q · filed 2022-11-03 | 27.59M shares derived: average of 4 quarters · filed 2022-11-03 | ||||
| 2021-06-30 | 27.61M shares 10-Q · filed 2022-08-04 | 27.60M shares 10-Q · filed 2022-08-04 | 27.59M shares derived: average of 3 quarters · filed 2022-08-04 | 27.58M shares derived: average of 4 quarters · filed 2022-08-04 | ||||
| 2021-03-31 | 27.60M shares 10-Q · filed 2022-05-05 | 27.58M shares derived: average of 2 quarters · filed 2022-05-05 | 27.57M shares derived: average of 3 quarters · filed 2022-05-05 | |||||
| 2020-12-31 | 27.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | 27.55M shares derived: average of 2 quarters · filed 2022-03-03 | 27.53M shares 10-K · filed 2022-03-03 | |||||
| 2020-09-30 | 27.55M shares 10-Q · filed 2021-11-04 | 27.52M shares 10-Q · filed 2021-11-04 | ||||||
| 2020-03-31 | 29.35M shares 10-Q · filed 2021-05-06 | |||||||
| 2019-03-31 | 1.38M shares 10-Q · filed 2020-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |